We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
-2.67%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.06B
AUM Growth
-$221M
(-9.7%)
Cap. Flow
-$22.1M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
18.33%
Holding
249
New
38
Increased
87
Reduced
99
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AAR Corp
AIR
|
+$23.4M |
| 2 |
RadNet
RDNT
|
+$13.8M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
+$13.8M |
| 4 |
CBAY
Cymabay Therapeutics
CBAY
|
+$13M |
| 5 |
Savers
SVV
|
+$12.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$32.3M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$27.5M |
| 3 |
Planet Fitness
PLNT
|
+$27.5M |
| 4 |
Super Micro Computer
SMCI
|
+$17.1M |
| 5 |
Petco
WOOF
|
+$14.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.32% |
| 2 | Industrials | 21.96% |
| 3 | Technology | 19.12% |
| 4 | Consumer Discretionary | 9.24% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Adobe
ADBE
$89.5B
| $429K | 0.02% |
842
| – | – |
|
177
Sarepta Therapeutics
SRPT
$1.66B
| $419K | 0.02% |
3,454
-72
| -2% | -$8.14K |
|
178
Helix Energy Solutions
HLX
$1.46B
| $411K | 0.02% |
+36,788
| New | +$354K |
|
179
Delta Air Lines
DAL
$55.9B
| $394K | 0.02% |
10,645
+2,863
| +37% | +$124K |
|
180
Align Technology
ALGN
$12B
| $392K | 0.02% |
1,285
-21
| -2% | -$7.26K |
|
181
Cloudflare
NET
$93B
| $379K | 0.02% |
+6,006
| New | +$385K |
|
182
Expedia Group
EXPE
$31.2B
| $377K | 0.02% |
3,658
+1,124
| +44% | +$124K |
|
183
Diamondback Energy
FANG
$57.6B
| $377K | 0.02% |
2,431
-51
| -2% | -$7.53K |
|
184
S&P Global
SPGI
$126B
| $376K | 0.02% |
1,029
-16
| -2% | -$6.29K |
|
185
Spotify
SPOT
$99.2B
| $367K | 0.02% |
2,371
-49
| -2% | -$7.46K |
|
186
Owens Corning
OC
$11.5B
| $339K | 0.02% |
2,484
-51
| -2% | -$7.01K |
|
187
Monolithic Power Systems
MPWR
$65.5B
| $333K | 0.02% |
720
-12
| -2% | -$6.14K |
|
188
T. Rowe Price
TROW
$25B
| $321K | 0.02% |
3,061
+1,034
| +51% | +$116K |
|
189
United Therapeutics
UTHR
$26.3B
| $311K | 0.02% |
1,376
-4,621
| -77% | -$1.06M |
|
190
Teradyne
TER
$54.8B
| $307K | 0.01% |
3,055
-64
| -2% | -$6.75K |
|
|
AYX
191
DELISTED
Alteryx Inc
AYX
| $304K | 0.01% |
8,072
-180
| -2% | -$6.45K |
|
192
Home Depot
HD
$332B
| $304K | 0.01% |
1,005
| – | – |
|
193
Brunswick
BC
$5.19B
| $301K | 0.01% |
3,804
-3,809
| -50% | -$314K |
|
194
Illumina
ILMN
$29.4B
| $291K | 0.01% |
2,176
-46
| -2% | -$7.56K |
|
195
Lattice Semiconductor
LSCC
$17.6B
| $279K | 0.01% |
3,250
-68
| -2% | -$6.14K |
|
196
Pool Corp
POOL
$6.7B
| $277K | 0.01% |
778
-369
| -32% | -$134K |
|
|
EBIX
197
DELISTED
Ebix Inc
EBIX
| $276K | 0.01% |
27,898
-8,969
| -24% | -$174K |
|
198
Rockwell Automation
ROK
$51.4B
| $268K | 0.01% |
938
+82
| +10% | +$25.4K |
|
199
Fortinet
FTNT
$112B
| $266K | 0.01% |
4,527
-7,639
| -63% | -$506K |
|
200
Moderna
MRNA
$21.5B
| $260K | 0.01% |
+2,521
| New | +$281K |
|
Similar funds
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
FAM
Emerald Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, Emerald Advisers held 249 positions worth $2.06B, down 9.7% from $2.29B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Emerald Advisers's Q3 2023 filing shows 38 new, 87 increased, 99 reduced and 17 closed positions. Its largest new stake was RadNet: 443,538 shares worth $12.5M. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $32.3M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Industrials and Technology.
- Emerald Advisers's largest Q3 2023 buy was RadNet: 443,538 shares worth $12.5M.
- Emerald Advisers added most to AAR Corp in Q3 2023, an estimated $23.4M increase.
- Emerald Advisers's biggest Q3 2023 reduction was Super Micro Computer, cutting an estimated $17.1M.
- Emerald Advisers fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $32.3M.
- Emerald Advisers's ten largest holdings make up 18% of its $2.06B portfolio in Q3 2023.
- Emerald Advisers opened 38 new positions and closed 17 in Q3 2023.
- Emerald Advisers's portfolio value fell 9.7% quarter-over-quarter to $2.06B.
Based on Emerald Advisers's 13F filing for Q3 2023, filed 26 Oct 2023.